Inventor
FISCHER NICOLAS
CH63 patents
⚠️ This page may combine multiple inventors who share the name “FISCHER NICOLAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVIMMUNE SA
19 patentsUS7728114B2Jun 1, 2010
Anti-CD3 antibodies and methods of use thereof
NOVIMMUNE SA260 citations98
US7786268B2Aug 31, 2010
Anti-IP-10 antibodies and methods of use thereof
NOVIMMUNE SA14 citations92
US7700098B2Apr 20, 2010
Anti-interferon gamma antibodies and methods of use thereof
NOVIMMUNE SA19 citations92
US9926382B2Mar 27, 2018
Methods for the generation of multispecific and multivalent antibodies
NOVIMMUNE SA16 citations90
US9682142B2Jun 20, 2017
Anti-interferon gamma antibodies and methods of use thereof
NOVIMMUNE SA9 citations84
US9850304B2Dec 26, 2017
Anti-CD3 antibodies and methods of use thereof
NOVIMMUNE SA5 citations83
US10047144B2Aug 14, 2018
Methods of purifying antibodies
NOVIMMUNE SA8 citations79
US11260117B2Mar 1, 2022
Anti-CD47 x anti-mesothelin antibodies and methods of use thereof
NOVIMMUNE SA4 citations72
US10759858B2Sep 1, 2020
Anti-CD3 antibodies and methods of use thereof
NOVIMMUNE SA1 citations72
US10400044B2Sep 3, 2019
Anti-TLR4 antibodies and uses thereof
NOVIMMUNE SA1 citations72
US10597465B2Mar 24, 2020
Methods for the generation of multispecific and multivalent antibodies
NOVIMMUNE SA1 citations71
US12448444B2Oct 21, 2025
Bispecific antibodies targeting CD47 and PD-L1 and methods of use thereof
NOVIMMUNE SA2 citations70
US10982004B2Apr 20, 2021
Anti-TLR4 antibodies and uses thereof
NOVIMMUNE SA0 citations61
US9453076B2Sep 27, 2016
Anti-TLR4 antibodies and uses thereof
NOVIMMUNE SA1 citations61
US11203646B2Dec 21, 2021
Anti-CD3 epsilon antibodies and methods of use thereof
NOVIMMUNE SA1 citations60
US11840553B2Dec 12, 2023
Anti-CD47 antibodies and methods of use thereof
NOVIMMUNE SA0 citations59
US11059910B2Jul 13, 2021
Anti-CD47 antibodies and methods of use thereof
NOVIMMUNE SA1 citations59
US11401299B2Aug 2, 2022
Generating multispecific antibody mixtures and methods of uses thereof
NOVIMMUNE SA0 citations51
US11261262B2Mar 1, 2022
Readily isolated bispecific binding molecules with native format having mutated constant regions
NOVIMMUNE SA0 citations49
NAGRAVISION SA
8 patentsUS7697686B2Apr 13, 2010
Unit for managing audio/video data and access control method for said data
NAGRAVISION SA62 citations95
US11018847B2May 25, 2021
Device keys protection
NAGRAVISION SA2 citations73
US10205588B2Feb 12, 2019
Device keys protection
NAGRAVISION SA4 citations73
US11496292B2Nov 8, 2022
Secure installation of application keys
NAGRAVISION SA3 citations72
US11366936B2Jun 21, 2022
Flexible cryptographic device
NAGRAVISION SA0 citations62
US11314518B2Apr 26, 2022
Verification of instructions from main processor to auxiliary processor
NAGRAVISION SA1 citations62
US8037339B2Oct 11, 2011
Security device intended to be connected to a processing unit for an audio/video signal and process using such a device
NAGRAVISION SA2 citations60
US11658954B2May 23, 2023
Pairing method between a multimedia unit and at least one operator, multimedia unit, operator and personalization entity for the implementation of this method
NAGRAVISION SA0 citations51
NAGRASTAR LLC
7 patentsUS9043902B2May 26, 2015
Apparatus for controlling processor execution in a secure environment
NAGRASTAR LLC6 citations83
US10382816B2Aug 13, 2019
Systems and methods for performing transport I/O
NAGRASTAR LLC1 citations72
US9769521B2Sep 19, 2017
Systems and methods for performing transport I/O
NAGRASTAR LLC2 citations72
US10070176B2Sep 4, 2018
Systems and methods for performing transport I/O
NAGRASTAR LLC1 citations61
US9888283B2Feb 6, 2018
Systems and methods for performing transport I/O
NAGRASTAR LLC1 citations61
US9774908B2Sep 26, 2017
Systems and methods for performing transport I/O
NAGRASTAR LLC1 citations61
US9485533B2Nov 1, 2016
Systems and methods for assembling and extracting command and control data
NAGRASTAR LLC0 citations51
FISCHER NICOLAS
6 patentsUS4091197AMay 23, 1978
Process for polymerization of vinyl chloride micro-suspension with metal compounds
FISCHER NICOLAS32 citations87
US9834615B2Dec 5, 2017
Methods for the generation of multispecific and multivalent antibodies
FISCHER NICOLAS5 citations82
US8258267B2Sep 4, 2012
Human anti-IP-10 antibodies uses thereof
FISCHER NICOLAS5 citations73
US8921281B2Dec 30, 2014
Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants
FISCHER NICOLAS4 citations69
US8716196B2May 6, 2014
Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants
FISCHER NICOLAS2 citations58
US8110661B2Feb 7, 2012
Anti-IP-10 antibodies and methods of use thereof
FISCHER NICOLAS0 citations51
NAGRAVISION SARL
4 patentsUS11876895B2Jan 16, 2024
Secure installation of application keys
NAGRAVISION SARL3 citations74
US12244691B2Mar 4, 2025
Secure installation of application keys
NAGRAVISION SARL0 citations62
US11977666B2May 7, 2024
Flexible cryptographic device
NAGRAVISION SARL0 citations62
US12526142B2Jan 13, 2026
Cryptography
NAGRAVISION SARL0 citations51
MACH BERNARD
1 patentMOREILLON GUY
1 patentCHLOE CHEMIE
1 patentNAGRACARD SA
1 patentLEGOCHEM BIOSCIENCES INC
1 patentNOV IMMUNE S A
1 patentShowing the top 50 of 63 patents by PatentIndex Score.